Antibody-based eye drop treatment reduces signs and symptoms of dry eye disease
Researchers at the University of Illinois at Chicago are the first to identify the presence of a specific type of antibody, called anti-citrullinated protein autoantibodies, or ACPAs, in human tear fluid.